← Back to Blog
October 5, 2026

Telehealth Peptide Content: A Claims Review Guide

Telehealth Peptides3 min readReviewed October 4, 2026MarketHealth Editorial Team

Telehealth Peptide Content: A Claims Review Guide

Clipboard marked compliance beside a gavel
Key takeaway

Review telehealth peptide content before publishing by removing healing, recovery, anti-aging and performance claims, wording regulatory status accurately with dates and sources, using approved creative with clear disclosures, and cutting any dosing, "stacks" or reconstitution content. Then run the pre-publish checklist.

Peptide content sits at the edge of what health marketing can say. A separate review step catches the claims that general health content reviews often miss.

Why peptide content needs a separate review

  • Many peptides discussed online aren't FDA-approved, and some aren't legal to compound.
  • Online peptide culture is full of dosing advice and recovery claims that don't belong in affiliate content.
  • Regulatory status changed twice in 2026, so accurate wording requires dates and sources.

Prohibited claims (healing, recovery, anti-aging, performance)

Remove Why
"Heals injuries," "repairs tendons" Disease and treatment claims
"Speeds recovery," "builds muscle" Unsubstantiated performance claims
"Reverses aging," "longevity peptide" Unsupportable anti-aging claims
"Clinically proven" Rarely supported for the specific product and use

Regulatory-status wording that stays accurate

  • Date every status statement: "As of October 2026..."
  • Link to a primary source: FDA announcements, advisory committee materials or warning letters.
  • Never describe an advisory vote or a Category 2 removal as approval.
  • Never call compounded peptides "FDA-approved."

See our 2026 regulation update for current status.

Disclosures and approved creative

  • Use only the advertiser's approved claims, images and landing pages.
  • Put a clear affiliate disclosure near the first recommendation, and in every video, email and post.
  • Don't use before-and-after physique images.

No dosing, stacks or reconstitution content

Dosing is a clinical decision. Affiliate content should never include doses, schedules, "stacks," injection guidance or reconstitution instructions, even framed as "what people report." FDA has treated bundled supplies and dosing tools on seller websites as evidence that products are intended for human use.

Pre-publish checklist

  • No healing, recovery, anti-aging or performance claims
  • Every regulatory statement is dated and sourced
  • No advisory vote or Category 2 removal described as approval
  • Compounded peptides not called FDA-approved
  • No dosing, stacks, protocols or reconstitution content
  • No links to research-use sellers
  • Approved creative and landing pages only
  • Disclosure near every recommendation

Frequently asked questions

Which peptide claims are prohibited?

Healing, injury recovery, anti-aging, muscle and performance claims, plus any claim the advertiser hasn't approved and substantiated.

Can I mention research studies?

Yes, carefully. Describe what a study looked at, its size and its limits, link to it, and don't present it as proof that a product works for your readers.

How do I describe compounded peptides?

As compounded medications prepared by a licensed pharmacy for a patient's prescription, which aren't FDA-approved, using the advertiser's approved wording.

What should I remove before publishing?

Outcome claims, dosing or protocol content, undated status statements, approval language that isn't accurate, and any link to a research-use seller.

Next stepRead the telehealth compliance guide

Practical guides and programs for health and beauty publishers.

Continue

Educational content for marketers and publishers, not medical, legal or financial advice. Examples labeled hypothetical are illustrations, not results. MarketHealth may earn revenue from programs it describes. See our affiliate disclosure and editorial policy.